Skip to content
← Survival collections

POPULATION SURVIVAL

HR+/HER2- Breast Cancer (Female only)

Published source values

Female · All Ages · All Stages · All Races / Ethnicities

Source
SEER
Table
Recent Trends
Data submission
November 2025 submission
Application release
Updated
June 22, 2026
Retrieved
Diagnosis years
2010 to 2022
5-year Relative Survival by diagnosis year for HR+/HER2- Breast Cancer (Female only). Source table: SEER Recent Trends.
Diagnosis yearRelative survival (%)Lower CIUpper CIStandard errorModeled (%)Source count
201094.36149193.99049994.7102290.18349894.24917242621
201194.85046994.49924795.1798420.17351294.47335146262
201294.45344694.10539994.7815160.17238894.68904047925
201394.64147494.30180994.9614370.16818194.89654049517
201495.07208894.74072395.3830860.16376795.09614450229
201595.51296195.19296095.8121300.15784195.28813752959
201695.32586595.00370795.6277330.15908695.47279354254
201795.60510395.28777895.9015220.15645495.65037955708
201895.58926995.27602395.8821950.15452895.82115358345
2019Not publishedNot publishedNot publishedNot published95.985363Not published
2020Not publishedNot publishedNot publishedNot published96.143251Not published
2021Not publishedNot publishedNot publishedNot published96.295050Not published
2022Not publishedNot publishedNot publishedNot published96.440986Not published

Open the SEER source

Filters stay in your browser. Some combinations have no estimate.

SEER · SOURCE POPULATIONS

Recent survival trends

Compare diagnosis years, not years since diagnosis. These estimates describe different diagnosis eras—not one person’s changing outlook.

Loading the exact source populations…

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Relative survival compares cancer populations with the general population. It is not the percentage of people alive, a treatment effect, or a personal forecast. Diagnosis-period dates were not labeled in the recovered package; see the source notes below.